FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3019923310> ?p ?o ?g. }

• W3019923310 abstract "Abstract Background Niemann-Pick disease Type C (NP-C) is a rare, progressive neurodegenerative disorder characterized by progressive neurodegeneration and premature death. We report data at closure of the NPC Registry that describes the natural history, disease course and treatment experience of NP-C patients in a real-world setting. Methods The NPC Registry was a prospective observational cohort study that ran between September 2009 and October 2017. Patients with a confirmed diagnosis of NP-C were enrolled regardless of treatment status. All patients underwent clinical assessments and medical care as determined by their physicians; data were collected through a secure internet-based portal. Results At closure on October 19, 2017, 472 patients from 22 countries were enrolled in the NPC Registry. Mean (standard deviation) age at enrollment was 21.2 (15.0) years, and 51.9% of patients were male. First neurological symptom onset occurred during the early-infantile (< 2 years), late-infantile (2 to < 6 years), juvenile (6 to < 15 years), or adolescent/adult (≥ 15 years) periods in 13.5, 25.6, 31.8, and 29.1% of cases, respectively. The most frequent neurological manifestations prior to enrollment included ataxia (67.9%), vertical supranuclear gaze palsy (67.4%), dysarthria (64.7%), cognitive impairment (62.7%), dysphagia (49.1%), and dystonia (40.2%). During infancy, splenomegaly and hepatomegaly were frequent ( n = 199/398 [50%] and n = 147/397 [37.0%], respectively) and persisted in most affected patients. Of the 472 enrolled patients, 241 were continuously treated with miglustat during the NPC Registry observation period, of whom 172 of these 241 patients were treated continuously for ≥12 months. A composite disability score that assesses impairment of ambulation, manipulation, language, and swallowing was highest in the early-infantile population and lowest in the adolescent/adult population. Among the continuous miglustat therapy population, 70.5% of patients had improved or had stable disease (at least 3 of the 4 domains having a decreased or unchanged score between enrollment and last follow-up). The NPC Registry did not identify any new safety signals associated with miglustat therapy. Conclusions The profiles of clinical manifestations in the final NPC Registry dataset agreed with previous clinical descriptions. Miglustat therapy was associated with a stabilization of neurological manifestations in most patients. The safety and tolerability of miglustat therapy was consistent with previous reports." @default.
• W3019923310 created "2020-05-01" @default.
• W3019923310 creator A5002770727 @default.
• W3019923310 creator A5005476344 @default.
• W3019923310 creator A5041731466 @default.
• W3019923310 creator A5067270123 @default.
• W3019923310 creator A5089005273 @default.
• W3019923310 creator A5090713236 @default.
• W3019923310 date "2020-04-25" @default.
• W3019923310 modified "2023-10-18" @default.
• W3019923310 title "Treatment outcomes following continuous miglustat therapy in patients with Niemann-Pick disease Type C: a final report of the NPC Registry" @default.
• W3019923310 cites W1965246606 @default.
• W3019923310 cites W1974316422 @default.
• W3019923310 cites W1982347529 @default.
• W3019923310 cites W2006281673 @default.
• W3019923310 cites W2020520190 @default.
• W3019923310 cites W2027570554 @default.
• W3019923310 cites W2047586147 @default.
• W3019923310 cites W2055816898 @default.
• W3019923310 cites W2068262899 @default.
• W3019923310 cites W2083930723 @default.
• W3019923310 cites W2105883407 @default.
• W3019923310 cites W2127795391 @default.
• W3019923310 cites W2137234884 @default.
• W3019923310 cites W2138034498 @default.
• W3019923310 cites W2144428362 @default.
• W3019923310 cites W2155503300 @default.
• W3019923310 cites W2157900484 @default.
• W3019923310 cites W2202947981 @default.
• W3019923310 cites W2301775287 @default.
• W3019923310 cites W2754552366 @default.
• W3019923310 cites W2765432893 @default.
• W3019923310 cites W2804385143 @default.
• W3019923310 cites W2885654157 @default.
• W3019923310 cites W2894514786 @default.
• W3019923310 cites W2917318257 @default.
• W3019923310 cites W3024300525 @default.
• W3019923310 doi "https://doi.org/10.1186/s13023-020-01363-2" @default.
• W3019923310 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7183679" @default.
• W3019923310 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32334605" @default.
• W3019923310 hasPublicationYear "2020" @default.
• W3019923310 type Work @default.
• W3019923310 sameAs 3019923310 @default.
• W3019923310 citedByCount "48" @default.
• W3019923310 countsByYear W30199233102020 @default.
• W3019923310 countsByYear W30199233102021 @default.
• W3019923310 countsByYear W30199233102022 @default.
• W3019923310 countsByYear W30199233102023 @default.
• W3019923310 crossrefType "journal-article" @default.
• W3019923310 hasAuthorship W3019923310A5002770727 @default.
• W3019923310 hasAuthorship W3019923310A5005476344 @default.
• W3019923310 hasAuthorship W3019923310A5041731466 @default.
• W3019923310 hasAuthorship W3019923310A5067270123 @default.
• W3019923310 hasAuthorship W3019923310A5089005273 @default.
• W3019923310 hasAuthorship W3019923310A5090713236 @default.
• W3019923310 hasBestOaLocation W30199233101 @default.
• W3019923310 hasConcept C118552586 @default.
• W3019923310 hasConcept C126322002 @default.
• W3019923310 hasConcept C141071460 @default.
• W3019923310 hasConcept C187212893 @default.
• W3019923310 hasConcept C195910791 @default.
• W3019923310 hasConcept C2779134260 @default.
• W3019923310 hasConcept C2780596822 @default.
• W3019923310 hasConcept C2780635549 @default.
• W3019923310 hasConcept C2780906641 @default.
• W3019923310 hasConcept C71924100 @default.
• W3019923310 hasConcept C72563966 @default.
• W3019923310 hasConceptScore W3019923310C118552586 @default.
• W3019923310 hasConceptScore W3019923310C126322002 @default.
• W3019923310 hasConceptScore W3019923310C141071460 @default.
• W3019923310 hasConceptScore W3019923310C187212893 @default.
• W3019923310 hasConceptScore W3019923310C195910791 @default.
• W3019923310 hasConceptScore W3019923310C2779134260 @default.
• W3019923310 hasConceptScore W3019923310C2780596822 @default.
• W3019923310 hasConceptScore W3019923310C2780635549 @default.
• W3019923310 hasConceptScore W3019923310C2780906641 @default.
• W3019923310 hasConceptScore W3019923310C71924100 @default.
• W3019923310 hasConceptScore W3019923310C72563966 @default.
• W3019923310 hasFunder F4320338282 @default.
• W3019923310 hasIssue "1" @default.
• W3019923310 hasLocation W30199233101 @default.
• W3019923310 hasLocation W30199233102 @default.
• W3019923310 hasLocation W30199233103 @default.
• W3019923310 hasOpenAccess W3019923310 @default.
• W3019923310 hasPrimaryLocation W30199233101 @default.
• W3019923310 hasRelatedWork W1992138464 @default.
• W3019923310 hasRelatedWork W1998848462 @default.
• W3019923310 hasRelatedWork W2164373547 @default.
• W3019923310 hasRelatedWork W2352348542 @default.
• W3019923310 hasRelatedWork W2383166333 @default.
• W3019923310 hasRelatedWork W2559941419 @default.
• W3019923310 hasRelatedWork W2774680161 @default.
• W3019923310 hasRelatedWork W2895036280 @default.
• W3019923310 hasRelatedWork W3082763462 @default.
• W3019923310 hasRelatedWork W2188213098 @default.
• W3019923310 hasVolume "15" @default.
• W3019923310 isParatext "false" @default.
• W3019923310 isRetracted "false" @default.
• W3019923310 magId "3019923310" @default.
• W3019923310 workType "article" @default.